Literature DB >> 8231207

Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia.

J A Hagen1, J H Peters, T R DeMeester.   

Abstract

The belief that transhiatal esophagogastrectomy results in the same survival as a more extensive en bloc resection was tested in 69 patients with carcinoma in the distal esophagus and gastric cardia. Preoperative and intraoperative staging defined three distinct subgroups of patients. Those with apparently limited disease and good general health (group I, n = 30) underwent en bloc resection. Those with apparently limited disease but poor physiologic reserve (group II, n = 16) underwent transhiatal resection, as did those with evidence of more advanced disease (group III, n = 23). Overall, survival was significantly better in the 30 patients who underwent en bloc resection (41%) than in the 39 patients who underwent transhiatal resections (14%; p < 0.001, log-rank). Clinical staging showed apparently limited disease in 46 patients (groups I and II). These groups differed only in the presence of poor physiologic reserve because the percentages of patients with tumors limited to the esophageal wall (group I 13/30, group II 6/16) and four or fewer lymph node metastases (group I 21/30, group II 15/16) at the time of pathologic staging were not significantly different. Survival after en bloc resection was, however, significantly better (41% versus 21%; p < 0.05, log-rank). According to the WNM system of pathologic staging, 19 patients had early lesions defined as intramural lesions associated with four or fewer lymph node metastases, 26 had intermediate lesions defined as either transmural or associated with more than four lymph node metastases, and 24 had late lesions defined as both transmural and associated with fewer than four lymph node metastases. Survival was significantly better in patients with early lesions after en bloc resection compared with transhiatal resection (75% versus 20%, p < 0.01), survival was also significantly better in patients with advanced lesions (27% versus 9%, p < 0.01). For intermediate lesions, the survival was similar (14% versus 20%), although the median survival after en bloc resection was longer (24 months versus 8 months).

Entities:  

Mesh:

Year:  1993        PMID: 8231207

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  23 in total

1.  Lymph node micrometastases in patients with adenocarcinoma of the esophagogastric junction.

Authors:  L Bonavina; S Ferrero; V Midolo; R Buffa; B Cesana; A Peracchia
Journal:  J Gastrointest Surg       Date:  1999 Sep-Oct       Impact factor: 3.452

Review 2.  Current management of esophageal cancer.

Authors:  Simon Law; John Wong
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

3.  Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma.

Authors:  Christophe Mariette; Laetitia Finzi; Guillaume Piessen; Isabelle Van Seuningen; Jean Pierre Triboulet
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

4.  Extended lymphadenectomy in esophageal cancer is crucial.

Authors:  Daniel Tong; Simon Law
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

5.  Should en bloc esophagectomy be the standard of care for esophageal carcinoma?

Authors:  N Altorki; D Skinner
Journal:  Ann Surg       Date:  2001-11       Impact factor: 12.969

6.  Transhiatal esophagectomy: clinical experience and refinements.

Authors:  M B Orringer; B Marshall; M D Iannettoni
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

Review 7.  Surgical management of esophageal malignancy.

Authors:  Dennis Blom
Journal:  Curr Gastroenterol Rep       Date:  2003-06

8.  Radical thoracoscopic esophagectomy for cancer.

Authors:  S P Dexter; I G Martin; M J McMahon
Journal:  Surg Endosc       Date:  1996-02       Impact factor: 4.584

9.  Results of surgical therapy in patients with Barrett's adenocarcinoma.

Authors:  Luigi Bonavina; Albert Via; Raffaello Incarbone; Greta Saino; Alberto Peracchia
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

Review 10.  Surgery of esophageal cancer.

Authors:  F G Uzunoglu; M Reeh; A Kutup; J R Izbicki
Journal:  Langenbecks Arch Surg       Date:  2013-01-25       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.